Delivery Order SPE2DB22D1202-SPE2DB22FGUC1
Award Date 8/18/22
Potential Completion Date 8/19/22
Potential Value $8.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the Defense Logistics Agency (DLA). The $1,536.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Erythromycin 0.5% eye ointment. The contract has a firm fixed price of $1,031.72 and a performance period ending on August 12, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,032.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564804557 - Erythromycin 0.5% eye ointment, 3.5 gm. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The $9,675.79 Firm Fixed Price Delivery Order is for the supply of Erythromycin 0.5% Eye Ointment, with an ultimate completion date of February 6, 2024. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,788.58 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,266.59, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,266.59 and an ultimate completion date of December 11, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract has no set-aside designation, indicating full and open...
- This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,374.00 Firm Fixed Price Delivery Order is for the supply of Erythromycin 0.5% eye ointment. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This federal contract award is for the delivery of ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,405.15 and an ultimate completion date of November 29, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units, with a ceiling value of $3,171.28. This firm fixed-price delivery order, which was not set-aside and competitively awarded, is scheduled for completion by November 13, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA), a key procurement agency for the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,246.50, is a Firm Fixed Price Delivery Order with a completion date of November 30, 2021. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB22FGUC1Delivery Order
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment (3.5 grams) to the Defense Logistics Agency (DLA). The $8,320.47 firm fixed-price delivery order was awarded on August 18, 2022 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 19, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order was not set aside for any socioeconomic program.
Generated 10/3/24, 9:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/18/22 |